Kymera Therapeutics, Inc. (KYMR) vs Protagonist Therapeutics, Inc. (PTGX)

Kymera Therapeutics, Inc. and Protagonist Therapeutics, Inc. are both Biotechnology companies. Kymera Therapeutics, Inc. and Protagonist Therapeutics, Inc. are of similar size ($9.7B and $8.9B). Kymera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 117×. Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 34.8%. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs −285.3%) and the higher return on invested capital (61.8% vs −26.7%). Across the 17 metrics below, Protagonist Therapeutics, Inc. leads on 13 and Kymera Therapeutics, Inc. on 4.